Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip G Morgan

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Molecular Genetics and Metabolism|April 26, 2020
Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial diseaseSimon C Johnson, Ernst-Bernhard Kayser, Rebecca Bornstein, et al.
Plos One|March 22, 2019
Relevance of experimental paradigms of anesthesia induced neurotoxicity in the mouseSimon C Johnson, Amanda Pan, Grace X Sun, et al.
Plos One|June 10, 2025
Disruption of adaptive immunity does not attenuate disease in the Ndufs4(-/-) model of Leigh syndromeAllison R Hanaford, Asheema Khanna, Vivian Truong, et al.
JCI Insight|January 20, 2022
Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndromeJulia C Stokes, Rebecca L Bornstein, Katerina James, et al.
Paediatric Anaesthesia|February 15, 2024
Impact of dietary ketosis on volatile anesthesia toxicity in a model of Leigh syndromeKira A Spencer, Miranda N Howe, Michael T Mulholland, et al.
Elife|July 13, 2021
Mechanisms underlying neonate-specific metabolic effects of volatile anestheticsJulia Stokes, Arielle Freed, Rebecca Bornstein, et al.
Neuropathology and Applied Neurobiology|April 29, 2024
Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndromeAllison R Hanaford, Asheema Khanna, Katerina James, et al.
Kidney International|November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseasesSimon C Johnson, Frank Martinez, Alessandro Bitto, et al.
The Journal of Biological Chemistry|August 25, 2011
Caenorhabditis elegans UCP4 protein controls complex II-mediated oxidative phosphorylation through succinate transportMatthew Pfeiffer, Ernst-Bernhard Kayzer, Xianmei Yang, et al.
Science (New York, N.Y.)|November 16, 2013
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndromeSimon C Johnson, Melana E Yanos, Ernst-Bernhard Kayser, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Molecular Genetics and Metabolism|April 26, 2020
Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial diseaseSimon C Johnson, Ernst-Bernhard Kayser, Rebecca Bornstein, et al.
Plos One|March 22, 2019
Relevance of experimental paradigms of anesthesia induced neurotoxicity in the mouseSimon C Johnson, Amanda Pan, Grace X Sun, et al.
Plos One|June 10, 2025
Disruption of adaptive immunity does not attenuate disease in the Ndufs4(-/-) model of Leigh syndromeAllison R Hanaford, Asheema Khanna, Vivian Truong, et al.
JCI Insight|January 20, 2022
Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndromeJulia C Stokes, Rebecca L Bornstein, Katerina James, et al.
Paediatric Anaesthesia|February 15, 2024
Impact of dietary ketosis on volatile anesthesia toxicity in a model of Leigh syndromeKira A Spencer, Miranda N Howe, Michael T Mulholland, et al.
Elife|July 13, 2021
Mechanisms underlying neonate-specific metabolic effects of volatile anestheticsJulia Stokes, Arielle Freed, Rebecca Bornstein, et al.
Neuropathology and Applied Neurobiology|April 29, 2024
Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndromeAllison R Hanaford, Asheema Khanna, Katerina James, et al.
Kidney International|November 26, 2018
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseasesSimon C Johnson, Frank Martinez, Alessandro Bitto, et al.
The Journal of Biological Chemistry|August 25, 2011
Caenorhabditis elegans UCP4 protein controls complex II-mediated oxidative phosphorylation through succinate transportMatthew Pfeiffer, Ernst-Bernhard Kayzer, Xianmei Yang, et al.
Science (New York, N.Y.)|November 16, 2013
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndromeSimon C Johnson, Melana E Yanos, Ernst-Bernhard Kayser, et al.
Pageof 6